Editorial: Targeted Chemotherapy? Platinum in BRCA1-Dysfunctional Breast Cancer

A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer --joint study Japan/U.S.

Note: This abstract is highly technical, but the significance is that there is a focus on clear cell ovarian cancer.

"...Our experiments have revealed strong candidate miRNAs and their target genes that may contribute to the pathogenesis of clear cell ovarian cancer..."

Hereditary breast and ovarian cancer: Referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the

Hereditary breast and ovarian cancer: Referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting:

2009 Yi and St Louis Ovarian Cancer at OneTrueMedia.com

see the Montage from last year's (2009) ovarian cancer ACOR & friends August weekend

Make photo slide shows at www.OneTrueMedia.com

Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.

"One-third of ovarian tumours show loss of WWOX expression, and this loss significantly associates with clear cell and mucinous histology, advanced stage, low progesterone receptor expression and poor survival, suggesting that WWOX status affects ovarian cancer progression and prognosis."

e-blogger Dave: The Invisible Stakeholder - Patient is not a third-person word.